U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 114 results

Status:
US Approved Rx (2025)
First approved in 2018

Class (Stereo):
CHEMICAL (RACEMIC)



Lofexidine is newly FDA approved in the United States under the brand name LUCEMYRA for the treatment of opioid withdrawal symptoms in adults. Lofexidine acts as an agonist to α2 adrenergic receptors. These receptors inhibit adenylyl cyclase activity...
Status:
US Approved Rx (2018)
First approved in 1999

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Dexmedetomide (biologically active dextroisomer of medetomidine) is an alpha2-adrenergic agonist which was approved by FDA for the sedation purposes. Upon administration the drug activates the alpha2 receptors thus inhibiting the release of norepinep...
Status:
US Approved Rx (2023)
First approved in 1996

Class (Stereo):
CHEMICAL (RACEMIC)



Mirtazapine, originally known as ORG 3770, was first synthesized by the Department of Medicinal Chemistry of NV Organon in the Netherlands (Kaspersen et al. 1989). First approved for use in major depression in the Netherlands in 1994, mirtazapine was...
Status:
US Approved Rx (2002)
First approved in 1996

Class (Stereo):
CHEMICAL (ACHIRAL)



Tizanidine is a short-acting drug for the management of spasticity. Tizanidine is an agonist at a2-adrenergic receptor sites and presumably reduces spasticity by increasing presynaptic inhibition of motor neurons. In animal models, tizanidine has no ...
Status:
US Approved Rx (2003)
First approved in 1994

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

Nefazodone hydrochloride (trade name Serzone) is an antidepressant drug marketed by Bristol-Myers Squibb. Its sale was discontinued in 2003 in some countries, due to the small possibility of hepatic (liver) injury, which could lead to the need for a ...
Status:
US Approved Rx (2005)
First approved in 1978

Class (Stereo):
CHEMICAL (ABSOLUTE)



Bromocriptine is an ergot derivative with potent dopamine receptor agonist activity, which activates post-synaptic dopamine receptors. Bromocriptine is indicated for the treatment of dysfunctions associated with hyperprolactinemia. Bromocriptine ther...
Status:
US Approved Rx (1987)
First approved in 1974

Class (Stereo):
CHEMICAL (ACHIRAL)



Clonidine is a centrally acting α2 adrenergic agonist and imidazoline receptor agonist used to treat high blood pressure, attention deficit hyperactivity disorder, anxiety disorders, tic disorders, withdrawal (from either alcohol, opioids, or smoking...
Status:
US Approved Rx (2008)
First approved in 1952

Class (Stereo):
CHEMICAL (ACHIRAL)



Phentolamine (trade name Regitine) is a reversible nonselective α-adrenergic antagonist used for the control of hypertensive emergencies, most notably due to pheochromocytoma. Phentolamine produces its therapeutic actions by competitively blocking al...
Status:
US Approved Rx (2005)
First approved in 1948

Class (Stereo):
CHEMICAL (ABSOLUTE)



The isolation and naming of ergotamine by Stoll occurred in 1925 but the complete elucidation of structure was not achieved until 1951, with synthesis following some 10 years later. Current sources of ergotamine include the isolation from field ergot...
Status:
US Approved Rx (1943)
First approved in 1943

Class (Stereo):
CHEMICAL (ABSOLUTE)



DL-Methamphetamine (also known as +/- Methamphetamin) is a central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal met...